Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
64.30    -1.90 (-2.87%)
Bid:
64.10
Ask:
64.40
Spread: 0.30 (0.468%)
Market Cap: £568.04m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Completion of share buyback programme

20 Nov 2025 07:00

RNS Number : 2623I
IP Group PLC
20 November 2025
Β 

20 November 2025

Β 

IP Group plc

Β 

Completion of Share Buyback Programme

Β 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), announces that on 18 November 2025 it successfully completed the Β£20m extension to its share buyback programme that was originally announced on 26 June 2025.Β 

Β 

Since commencing its buyback programme, the Group has purchased 157,968,634 shares at an average price of 47.5 pence per share for an aggregate consideration of Β£75m ("the Buyback Programme"). All shares acquired under the Buyback Programme have been, or will shortly be, cancelled.

Β 

Following such cancellation, the Company's issued share capital consists of 883,427,642 Ordinary Shares with voting rights and there are no Ordinary Shares held in treasury. This figure may be used by shareholders as the denominator for the calculations by which they should determine if they are required to notify their interest in, orΒ change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Β 

Share buybacks will remain an important part of IP Group's Capital Allocation Policy. The Group will keep further buybacks under review, subject to the achievement of additional realisations within the portfolio.

Β 

For more information, please contact:

Β 

IP Group plc

Β 

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Β 

Portland

Alex Donaldson

+44 (0) 7516 729702

Β 

Notes for editors

Β 

About IP Group

Β 

IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech. Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, Featurespace, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London

Β 

ENDS

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCEAEFNFELSFAA
Date   Source Headline
16th Jul 20255:16 pmRNSTransaction in Own Shares
15th Jul 20255:13 pmRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20255:03 pmRNSTransaction in Own Shares
10th Jul 20255:18 pmRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:56 amRNSTransaction in Own Shares
7th Jul 20255:29 pmRNSTransaction in Own Shares
4th Jul 20255:11 pmRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20255:28 pmRNSTransaction in Own Shares
30th Jun 20255:29 pmRNSTotal Voting Rights
30th Jun 20255:27 pmRNSTransaction in Own Shares
26th Jun 20254:19 pmRNSShare buyback programme update
25th Jun 20257:05 amRNSHolding(s) in Company
25th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20255:54 pmRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20255:21 pmRNSTransaction in Own Shares
17th Jun 20256:12 pmRNSTransaction in Own Shares
16th Jun 20256:12 pmRNSTransaction in Own Shares
13th Jun 20255:11 pmRNSTransaction in Own Shares
12th Jun 20255:44 pmRNSTransaction in Own Shares
12th Jun 202512:54 pmRNSResult of AGM
11th Jun 20255:18 pmRNSTransaction in Own Shares
11th Jun 20254:43 pmRNSTransaction in Own Shares - Amendment
11th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20255:31 pmRNSTransaction in Own Shares
6th Jun 20256:03 pmRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20254:51 pmRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTotal Voting Rights
2nd Jun 20255:36 pmRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSPortfolio company AccelerComm raises $15m funding
30th May 20256:29 pmRNSTransaction in Own Shares
29th May 20255:55 pmRNSTransaction in Own Shares
28th May 20256:15 pmRNSTransaction in Own Shares
28th May 20254:05 pmRNSHolding(s) in Company
27th May 20255:11 pmRNSTransaction in Own Shares
23rd May 20256:29 pmRNSTransaction in Own Shares
22nd May 20255:15 pmRNSTransaction in Own Shares
22nd May 20252:13 pmRNSHinge Health IPO priced at top end of the range
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 202510:21 amRNSNotice of Capital Markets Event
21st May 20257:00 amRNSTransaction in Own Shares
19th May 20255:29 pmRNSTransaction in Own Shares
16th May 20255:42 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.